ClinicalTrials.Veeva

Menu

Skin Microcirculation in Patients With Lower Limb Atherosclerosis (SMILLA)

O

ODI Medical

Status

Enrolling

Conditions

Atherosclerosis of Arteries of the Extremities, Unspecified
Percutaneous Transluminal Angioplasty

Treatments

Device: Examination with the ODI-Tech medical device

Study type

Interventional

Funder types

Industry

Identifiers

NCT07312383
CIV-NO-25-10-054857

Details and patient eligibility

About

The aim of this study is to explore the ability of the non-invasive device ODI-Tech® to monitor changes in microvascular blood flow in patients with lower limb ischemia undergoing the procedure percutaneous transluminal angioplasty (PTA). Microvascular data from patients and healthy case matched controls at baseline will be compared.15 patients and 15 healthy case matched controls will be enrolled.

Full description

This clinical investigation is designed as a prospective study of limb skin nutritive capillary perfusion and oxygen extraction in patients with lower limb atherosclerosis and severe symptoms before and following elective PTA.

15 patients with critical lower limb atherosclerosis and ischemia in Rutherford grade 3 - 6 undergoing PTA, as well as 15 healthy case matched controls will be enrolled. Measurements will be performed at baseline, prior to PTA, immediately after PTA, 1 day and 30 days post PTA. Healthy case matched controls will be measured at baseline.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age ≥18
  • Lower limb atherosclerosis and ischemia in Rutherford grade 3-6
  • Obstructive infra-inguinal arterial lesions combined with open distal part of the anterior tibial artery
  • Scheduled for elective PTA
  • Able to give informed consent

Exclusion criteria

  • Active skin infection at the region of interest (site to be examined, dorsum of hand and foot)

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Patients scheduled for elective PTA
Other group
Treatment:
Device: Examination with the ODI-Tech medical device

Trial contacts and locations

1

Loading...

Central trial contact

Inger Hilde Zahl, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems